Market News
Post-Earnings Prospects: Morgan Stanley’s Insights
Post-Earnings Prospects: Morgan Stanley’s Insights
deepblue4you Morgan Stanley’s Mike Wilson has identified eight stocks that could experience an upswing in share prices following their Q4 results. Notable companies on ...
Insiders Make Notable Purchases in Penny Stocks, Indicating Confidence
The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern ...
Ghana secures 5% stake in Atlantic Lithium
Ghana’s Significant Investment in Atlantic Lithium Ghana’s Strategic Move Recently, Ghana Investment Funds for Electronic, Electrical and Automotive Industries (MIIF) has taken a substantial ...
Netflix’s Strong Q4 Sales Propel Dow Upwards
U.S. equities soared this morning, with the Dow Jones index surging over 100 points on Wednesday. As the market greeted Wednesday, the Dow climbed ...
ESE Entertainment Leverages Metapro Partnership to Tap Into Cryptocurrency Momentum
A New Era for Bitcoin ETFs In a bold move, the U.S. securities regulator has given the nod to the first U.S.-listed exchange-traded funds ...
Netflix’s Skyrocketing Stock Forces Wall Street to Play Catch Up
Netflix’s Skyrocketing Stock Forces Wall Street to Play Catch Up
Giuliano Benzin Netflix’s (NASDAQ:NFLX) incredible surge, fueled in part by its performance in the fourth quarter, has compelled Wall Street to do something it ...
Netflix Analyst Forecasts: Keybanc Raises Target to $580
Netflix Analyst Forecasts: Keybanc Raises Target to $580
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, ...
Exciting Energy Stocks Poised for Explosive Growth
Exciting Energy Stocks Poised for Explosive Growth
Undervalued companies in the energy sector present a compelling opportunity for investors. Considered oversold when the RSI is below 30, these stocks are primed ...
Theratechnologies Faces FDA Rejection of New Egrifta Version
Theratechnologies Faces FDA Rejection of New Egrifta Version
Grandbrothers Canadian biotech Theratechnologies (NASDAQ:THTX) revealed Wednesday that the U.S. Food and Drug Administration (FDA) declined to approve a new formulation of Egrifta, a ...
